Immunobiology of Cancer

Trial ID or NCT#

NCT00767533

Status

not recruiting iconNOT RECRUITING

Purpose

To learn whether or not an Interferon defect in cell signaling, recently discovered in immune cells from melanoma patients as well as breast cancer patients, is common to all cancers.

Official Title

Immunobiology of Cancer

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. Participants who have cancer or participants who do not have cancer and/or an autoimmune disorder and are age 18 or over.
Exclusion Criteria:
  1. Participants who have an autoimmune disorder and/or are under the age of 18 years.
View All Criteria
Show Less

Investigator(s)

Heather Wakelee
Heather Wakelee
Medical oncologist, Thoracic specialist
Winston Chen and Phyllis Huang Professor

Contact us to find out if this trial is right for you.

Contact

ccto-office@stanford.edu
650-498-7061

View on ClinicalTrials.gov